Childhood obesity and insulin resistance in a Yucatan mini-piglet model: Putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development

International Journal of Obesity

Volumn 29, Issue 3, 2005, Pages 324-333

  Sebert S P ^a   Lecannu, G ^a   Kozlowski, F ^a   Siliart, B ^b   Bard, J M ^c,d   Krempf, M ^d   Champ, M M J ^a,d  

^a CEMAGREF   (France)

^b Laboratoire des Dosages Hormonaux   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

ICF 1; Insulin resistance; Mini pigs; PPAR

Indexed keywords

FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 6; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY SIZE; BODY WEIGHT; CHILDHOOD DISEASE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE MODEL; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER LEVEL; MALE; MINIPIG; NONHUMAN; OBESITY; OVERNUTRITION; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SEXUAL MATURITY; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; AGING; ANIMALS; ANTHROPOMETRY; BODY WEIGHT; CHILD; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LIVER; MALE; MUSCLE, SKELETAL; OBESITY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; SEXUAL MATURATION; SWINE; SWINE, MINIATURE;

ANIMALIA; SUS SCROFA;

EID: 14744300093     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802823     Document Type: Article

References (61)

1. Jolliffe D. Extent of overweight among US children and adolescents from 1971 to 2000. Int J Obes Relat Metab Disord 2004; 28: 4-9.
2. Jebb SA, Lambert J. Overweight and obesity in European children and adolescents. Eur J Pediatr 2000; 159 (Suppl 1): S2-S4.
3. Rolland-Cachera MF, Castetbon K, Arnault N, Bellisle F, Romano MC, Lehingue Y, Frelut ML, Hercberg S. Body mass index in 7-9-y-old French children: frequency of obesity, overweight and thinness. Int J Obes Relat Metab Disord 2002; 26: 1610-1616.
4. Moran R. Evaluation and treatment of childhood obesity. Am Fam Physician 1999; 59: 861-868, 871-873.
5. Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132: 501-513.
6. Han TS, Richmond P, Avenell A, Lean ME. Waist circumference reduction and cardiovascular benefits during weight loss in women. Int J Obes Relat Metab Disord 1997; 21: 127-134.
7. Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA 1978; 240: 1607-1610.
8. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
9. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
10. Groop L. Genetics of the metabolic syndrome. Br J Nutr 2000; 83 (Suppl 1): S39-S48.
11. Ducluzeau PH, Perretti N, Laville M, Andreelli F, Vega N, Riou JP, Vidal H. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Diabetes 2001; 50: 1134-1142.
12. Hayashibe H, Asayama K, Nakane T, Uchida N, Kawada Y, Nakazawa S. Increased plasma cholesteryl ester transfer activity in obese children. Atherosclerosis 1997; 129: 53-58.
13. Franklin Jr FA, Dashti N, Franklin CC. Evaluation and management of dyslipoproteinemia in children. Endocrinol Metab Clin North Am 1998; 27: 641-654.
14. Young-Hyman D, Schlundt DG, Herman L, De Luca F, Counts D. Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American children. Diabetes Care 2001; 24: 1359-1364.
15. Youssef AA, Valdez R, Elkasabany A, Srinivasan SR, Berenson GS. Time-course of adiposity and fasting insulin from childhood to young adulthood in offspring of parents with coronary artery disease: the Bogalusa Heart Study. Ann Epidemiol 2002; 12: 553-559.
16. Wright CM, Parker L, Lamont D, Craft AW. Implications of childhood obesity for adult health: findings from thousand families cohort study. BMJ 2001; 323: 1280-1284.
17. Maffeis C, Moghetti P, Grezzani A, Clementi M, Gaudino R, Tato L. Insulin resistance and the persistence of obesity from childhood into adulthood. J Clin Endocrinol Metab 2002; 87: 71-76.
18. Srinivasan SR, Freedman DS, Sundaram GS, Webber LS, Berenson GS. Racial (black-white) comparisons of the relationship of levels of endogenous sex hormones to serum lipoproteins during male adolescence: the Bogalusa Heart Study. Circulation 1986; 74: 1226-1234.
19. Jiang X, Srinivasan SR, Dalferes Jr ER, Berenson GS. Plasma insulin-like growth factor 1 distribution and its relation to blood pressure in adolescents: the Bogalusa Heart Study. Am J Hypertens 1997; 10: 714-719.
20. Louveau I, Quesnel H, Prunier A. GH and IGF-I binding sites in adipose tissue, liver, skeletal muscle and ovaries of feed-restricted gilts. Reprod Nutr Dev 2000; 40: 571-578.
21. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131: 3109S-3120S.
22. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 2001; 50: 1110-1118.
23. Wabitsch M, Blum WF, Muche R, Heinze E, Haug C, Mayer H, Teller W. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls. Int J Obes Relat Metab Disord 1996; 20: 1073-1080.
24. Gayet C, Bailhache E, Dumon H, Martin L, Siliart B, Nguyen P. Insulin resistance and changes in plasma concentration of TNFalpha, IGF1, and NEFA in dogs during weight gain and obesity. J Anim Physiol Anim Nutr (Berl) 2004; 88: 157-165.
25. Phillips RW, Panepinto LM, Will DH. Genetic selection for diabetogenic traits in Yucatan miniature swine. Diabetes 1979; 28: 1102-1107.
26. Gerrity RG, Natarajan R, Nadler JL, Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001; 50: 1654-1665.
27. Bollen JA, Hansen AK, Rasmussen HJ. The Laboratory Swine. CRC press: Boca Raton, FL; 1999.
28. Bailhache E, Ouguerram K, Gayet C, Krempf M, Siliart B, Magot T, Nguyen P. An insulin-resistant hypertriglyceridaemic normotensive obese dog model: assessment of insulin resistance by the euglycaemic hyperinsulinaemic clamp in combination with the stable isotope technique. J Anim Physiol Anim Nutr (Berl) 2003; 87: 86-95.
29. Reinauer H, Gries FA, Hubinger A, Knode O, Severing K, Susanto F. Determination of glucose turnover and glucose oxidation rates in man with stable isotope tracers. J Clin Chem Clin Biochem 1990; 28: 505-511.
30. Janke J, Engeli S, Gorzelniak K, Sharma AM. Extraction of total RNA from adipocytes. Horm Metab Res 2001; 33: 213-215.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
32. Johansen T, Hansen HS, Richelsen B, Malmlof R. The obese Gottingen minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile. Comp Med 2001; 51: 150-155.
33. Larsen MO, Rolin B, Wilken M, Carr RD, Svendsen O. High-fat high-energy feeding impairs fasting glucose and increases fasting insulin levels in the Gottingen minipig: results from a pilot study. Ann NY Acad Sci 2002; 967: 414-423.
34. Heude B, Lafay L, Borys JM, Thibult N, Lommez A, Romon M, Ducimetiere P, Charles MA. Time trend in height, weight, and obesity prevalence in school children from Northern France. Diabetes Metab 2003; 29: 235-240.
35. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. Inter-relationships among childhood BMI, childhood height, and adult obesity: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2004; 28: 10-16.
36. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990; 10: 497-511.
37. Boden G. Fatty acids and insulin resistance. Diabetes Care 1996; 19: 394-395.
38. Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, Sturek M. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol 1999; 19: 2981-2992.
39. Bailhache E, Nguyen P, Krempf M, Siliart B, Magot T, Ouguerram K. Lipoproteins abnormalities in obese insulin-resistant dogs. Metabolism 2003; 52: 559-564.
40. Pedersen O, Kahn CR, Kahn BB. Divergent regulation of the Glut 1 and Glut 4 glucose transporters in isolated adipocytes from Zucker rats. J Clin Invest 1992; 89: 1964-1973.
41. Pawlak DB, Bryson JM, Denyer GS, Brand-Miller JC. High glycemic index starch promotes hypersecretion of insulin and higher body fat in rats without affecting insulin sensitivity. J Nutr 2001; 131: 99-104.
42. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 1997; 46: 1319-1327.
43. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994; 8: 1224-1234.
44. Muoio DM, Way JM, Tanner CJ, Winegar DA, Kliewer SA, Houmard JA, Kraus WE, Dohm GL. Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 2002; 51: 901-909.
45. Cha BS, Ciaraldi TP, Carter L, Nikoulina SE, Mudaliar S, Mukherjee R, Paterniti Jr JR, Henry RR. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Diabetologia 2001; 44: 444-452.
46. Hu E, Tontonoz P, Spiegelman BM. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci USA 1995; 92: 9856-9860.
47. Klindt J, Buonomo FC, Yen JT. Influence of porcine somatotropin administration and sex on glucose and endocrine responses in obese pigs. Proc Soc Exp Biol Med 1994; 207: 48-56.
48. Wang Y, Eleswarapu S, Beal WE, Swecker Jr WS, Akers RM, Jiang H. Reduced serum insulin-like growth factor (IGF) I is associated with reduced liver IGF-I mRNA and liver growth hormone receptor mRNA in food-deprived cattle. J Nutr 2003; 133: 2555-2560.
49. Gerfault V, Louveau I, Mourot J. The effect of GH and IGF-I on preadipocytes from large white and Meishan pigs in primary culture. Gen Comp Endocrinol 1999; 114: 396-404.
50. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 1988; 263: 9402-9408.
51. Di Cola G, Cool MH, Accili D. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J Clin Invest 1997; 99: 2538-2544.
52. Vickers MH, Ikenasio BA, Breier BH. IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming. Endocrinology 2001; 142: 3964-3973.
53. Nam SY, Marcus C. Growth hormone and adipocyte function in obesity. Horm Res 2000; 53 (Suppl 1): 87-97.
54. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338-3342.
55. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis. Endocr Rev 2001; 22: 53-74.
56. Marques BG, Hausman DB, Latimer AM, Kras KM, Mullen Grossman B, Martin RJ. Insulin-like growth factor I mediates high-fat diet-induced adipogenesis in Osborne-Mendel rats. Am J Physiol Regulat Integrative Comp Physiol 2000; 278: R654-R662.
57. Nisoli E, Carruba MO, Tonello C, Macor C, Federspil G, Vettor R. Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion. Diabetes 2000; 49: 319-324.
58. Tu W, Cheung PT, Lau YL. IGF-I increases interferon-gamma and IL-6 mRNA expression and protein production in neonatal mononuclear cells. Pediatr Res 1999; 46: 748-754.
59. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, Martini A, Ciliberto G, Fattori E. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997; 99: 643-650.
60. Bruce CR, Dyck DJ. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab 2004; 287: E616-E621.
61. Vernon RG, Barber MC, Travers MT. Present and future studies on lipogenesis in animals and human subjects. Proc Nutr Soc 1999; 58: 541-549.